NetworkNewsBreaks — Zevra Therapeutics Inc. (NASDAQ: ZVRA) Names New President, CEO and Director
Zevra Therapeutics (NASDAQ GS: ZVRA), a rare-disease therapeutics company, has named Neil F. McFarlane as president and CEO; McFarlane will also serve on the company’s board of directors. The new appointments are effective immediately. According to the announcement, Christal M.M. Mickle, who has been serving as interim CEO and president since June, will continue serving in her role as chief development officer. A former officer and enlisted soldier in the United States Army Reserves, McFarlane has an impressive, results-driven track record as a biopharmaceutical leader with proven ability to accelerate Zevra’s strategy of melding science, data and patient needs to…







